Summary

Global Recanalization Devices Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Recanalization devices are tools used in the field of medicine, particularly in interventional radiology and vascular surgery, to reopen or restore the patency of blood vessels that have become blocked or narrowed due to disease or other conditions. These devices are designed to navigate through the blood vessels to the site of obstruction or stenosis, where they can mechanically remove or push aside the blockage, allowing blood flow to resume. The Recanalization Devices market is expanding because of factors such as the increasing prevalence of cardiovascular diseases, rising awareness and screening programs for vascular disease, and the growing geriatric population.

As the global population ages and lifestyles change, the incidence of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and stroke is rising. This trend creates a growing demand for recanalization devices to treat blocked or narrowed blood vessels. The rising prevalence of cardiovascular diseases not only increases the demand for recanalization devices but also underscores the importance of innovation in this field. Thus, the rising prevalence of cardiovascular diseases is fueling the demand for recanalization devices as healthcare systems seek effective solutions to address the growing burden of these conditions. This trend is expected to drive continued growth and expansion of the recanalization devices market in the coming years. The Centers for Disease Control and Prevention (CDC) 2022 report states that in 2020, 20.1 million persons aged 20 and older had coronary artery disease. Furthermore, the same report stated that every year about 805,000 Americans have a heart attack which is projected to reach 13,000,000 by the year 2060. Thus, the rising prevalence of cardiac vascular disease is driving the market growth. In addition, rising preference towards minimally invasive techniques and rising technological advancement in devices are creating new opportunities for market growth. However, the high cost of recanalization devices and limited reimbursement policy stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Recanalization Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. North America is projected to maintain its leading position in the recanalization devices market throughout the forecast period. This dominance stems from the region's robust presence of well-established players engaged in manufacturing, developing, and bringing recanalization devices to market for addressing endovascular and fallopian tube conditions. Additionally, the prevalence of an aging population in North America significantly elevates the occurrence of such conditions, thereby fostering greater adoption of recanalization devices in this geographical area. Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to factors such as e rising healthcare expenditure observed in countries like India and China. Furthermore, government agencies and employer-sponsored health insurance initiatives aimed at offering advanced treatments for cardiovascular diseases, which often necessitate the use of recanalization devices, are propelling market growth in this region.

Major market players included in this report are:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Terumo Corporation
Cook Medical LLC
Cordis Corporation (a Cardinal Health company)
Johnson & Johnson
Penumbra, Inc.
Stryker Corporation
BTG International Ltd.

Recent Developments in the Market:
 In June 2023, MicroVention Inc., a subsidiary of Terumo Medical Corporation, introduced its Eric retrieval device in the U.S. market for treating ischemic stroke. The device had previously obtained clearance from the U.S. FDA 510(k) in March 2022. This expands the range of treatment options available within the recanalization devices market, potentially leading to increased adoption by healthcare providers.
 In February 2022, CERENOVUS, a division of Johnson & Johnson Services, Inc., unveiled EMBOGUARD, a cutting-edge balloon guide catheter designed for use in various endovascular procedures, particularly in individuals experiencing acute ischemic stroke. The introduction of EMBOGUARD represents a technological advancement in the field of recanalization devices. Its innovative features and capabilities may set a new standard for performance, prompting competitors to invest in research and development to stay competitive. This could lead to overall advancements in recanalization device technology.

Global Recanalization Devices Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Product, Application, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
 Customization Scope - Free report customization (equivalent to up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Catheters
Stents
Balloons
Guidewires
Others
By Application:
Fallopian Tube Recanalization
Endovascular Recanalization
Others
By End User:
Hospitals
Specialty Clinics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Recanalization Devices Market, by Region, 2020-2030 (USD Billion)
1.2.2. Recanalization Devices Market, by Product, 2020-2030 (USD Billion)
1.2.3. Recanalization Devices Market, by Application, 2020-2030 (USD Billion)
1.2.4. Recanalization Devices Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Recanalization Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Recanalization Devices Market Dynamics
3.1. Recanalization Devices Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Prevalence of Cardiovascular Diseases
3.1.1.2. Rising Awareness and Screening Programs for Vascular Diseases
3.1.1.3. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Recanalization Devices
3.1.2.2. Limited Reimbursement Policy
3.1.3. Market Opportunities
3.1.3.1. Rising Preference Towards Minimally Invasive Techniques
3.1.3.2. Rising Technological Advancement
Chapter 4. Global Recanalization Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Recanalization Devices Market, by Product
5.1. Market Snapshot
5.2. Global Recanalization Devices Market by Product, Performance - Potential Analysis
5.3. Global Recanalization Devices Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Recanalization Devices Market, Sub Segment Analysis
5.4.1. Catheters
5.4.2. Stents
5.4.3. Balloons
5.4.4. Guidewires
5.4.5. Others
Chapter 6. Global Recanalization Devices Market, by Application
6.1. Market Snapshot
6.2. Global Recanalization Devices Market by Application, Performance - Potential Analysis
6.3. Global Recanalization Devices Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Recanalization Devices Market, Sub Segment Analysis
6.4.1. Fallopian Tube Recanalization
6.4.2. Endovascular Recanalization
6.4.3. Others
Chapter 7. Global Recanalization Devices Market, by End User
7.1. Market Snapshot
7.2. Global Recanalization Devices Market by End User, Performance - Potential Analysis
7.3. Global Recanalization Devices Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Recanalization Devices Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Specialty Clinics
7.4.3. Others
Chapter 8. Global Recanalization Devices Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Recanalization Devices Market, Regional Market Snapshot
8.4. North America Recanalization Devices Market
8.4.1. U.S. Recanalization Devices Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Recanalization Devices Market
8.5. Europe Recanalization Devices Market Snapshot
8.5.1. U.K. Recanalization Devices Market
8.5.2. Germany Recanalization Devices Market
8.5.3. France Recanalization Devices Market
8.5.4. Spain Recanalization Devices Market
8.5.5. Italy Recanalization Devices Market
8.5.6. Rest of Europe Recanalization Devices Market
8.6. Asia-Pacific Recanalization Devices Market Snapshot
8.6.1. China Recanalization Devices Market
8.6.2. India Recanalization Devices Market
8.6.3. Japan Recanalization Devices Market
8.6.4. Australia Recanalization Devices Market
8.6.5. South Korea Recanalization Devices Market
8.6.6. Rest of Asia Pacific Recanalization Devices Market
8.7. Latin America Recanalization Devices Market Snapshot
8.7.1. Brazil Recanalization Devices Market
8.7.2. Mexico Recanalization Devices Market
8.8. Middle East & Africa Recanalization Devices Market
8.8.1. Saudi Arabia Recanalization Devices Market
8.8.2. South Africa Recanalization Devices Market
8.8.3. Rest of Middle East & Africa Recanalization Devices Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Medtronic plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Boston Scientific Corporation
9.3.3. Abbott Laboratories
9.3.4. Terumo Corporation
9.3.5. Cook Medical LLC
9.3.6. Cordis Corporation (a Cardinal Health company)
9.3.7. Johnson & Johnson
9.3.8. Penumbra, Inc.
9.3.9. Stryker Corporation
9.3.10. BTG International Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption